Research and development expenses were $4,800,000 compared to $4,700,000 in the prior year period and $4,200,000 in the prior quarter. Selling, general and administrative expenses were $2,600,000 in the quarter ended September 30, 2024 compared to $2,500,000 in the prior year quarter and $2,600,000 in the previous quarter. 2nd quarter fiscal 2025 operating loss was $5,600,000 compared to an operating loss of $4,100,000 in the prior year period and operating income of $1,100,000 in the prior quarter. 2nd quarter fiscal 2025 net income included interest and other income of $149,000 and a tax provision of $23,000 compared to $71,000 in interest and other income and a tax provision of $33,000 for the same period a year ago. In the preceding Q1, net loss included interest and other income of $55,000 and a tax provision of $57,000 Net loss in the Q2 of fiscal 2025 was $5,400,000 or $0.21 per diluted share compared to net loss of $4,100,000 or $0.16 per diluted share for the Q2 of fiscal 2024 and net income of $1,100,000 or $0.04 per diluted share inclusive of one time gain of $5,700,000 on the sale leaseback transaction related to the sale of the company's headquarters for the Q1 of fiscal 2025.